This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Molson Coors Brewing (TAP) Beats Q2 Earnings Estimates
by Zacks Equity Research
Molson Coors (TAP) delivered earnings and revenue surprises of 9.20% and 1.27%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Consumer Centric Stocks to Buy as Earnings Approach
by Shaun Pruitt
These consumer-centric companies are expected to have posted strong quarterly growth and now may be a good time to buy their stocks for a strengthening outlook.
Factors Likely to Influence AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
AB InBev (BUD) Q2 results are expected to reflect the benefits of its unique commercial strategy, a strong brand portfolio, and investments in brands and operation excellence.
Here's What Awaits Clorox (CLX) When It Reports Q4 Earnings
by Zacks Equity Research
Clorox's (CLX) Q4 results are expected to reflect gains from solid demand trends, pricing actions, digital investments, cost-saving efforts and the IGNITE strategy.
5 Large-Cap Stocks to Buy Ahead of Q2 Earnings Tomorrow
by Nalak Das
We have narrowed our search to five large-cap stocks that are set to declare second-quarter earnings results on Aug 1. These are: PEG, PAYC, MPLX, TAP, ECL.
FEMSA (FMX) Q2 Earnings Top Estimates on Solid Revenue Growth
by Zacks Equity Research
FEMSA's (FMX) Q2 results reflect gains from strong top-line growth across its business units, gross margin expansion and the inclusion of Proximity Europe.
Factors Likely to Influence Diageo's (DEO) FY23 Earnings
by Zacks Equity Research
Diageo's (DEO) fiscal 2023 results are expected to reflect gains from its effective marketing, strong commercial execution and favorable industry trends of premiumization.
Is a Beat in Store for Molson Coors (TAP) in Q2 Earnings?
by Zacks Equity Research
Despite inflation, Molson Coors' (TAP) second-quarter results are expected to reflect strength in core brands, a revitalization plan and the premiumization of its global portfolio.
Altria Group (MO) Queues for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Altria Group's (MO) second-quarter results are likely to reflect gains from pricing and strength in Oral Tobacco Products, though soft cigarette volumes have been a concern.
Coca-Cola (KO) Beats on Q2 Earnings & Revenues, Raises View
by Zacks Equity Research
Coca-Cola (KO) Q2 results benefit from revenue growth across most of its operating segments, aided by an improved price/mix and increased concentrate sales.
Here's Why Procter & Gamble (PG) is Poised for Q4 Earnings Beat
by Zacks Equity Research
Procter & Gamble's (PG) unwavering commitment to leverage its brand strength and adopt effective strategies has been bolstering its organic sales and market position.
Molson Coors Brewing (TAP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Molson Coors (TAP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Has KimberlyClark (KMB) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Kimberly-Clark (KMB) and Molson Coors Brewing (TAP) have performed compared to their sector so far this year.
Factors to Note Ahead of FEMSA's (FMX) Upcoming Q2 Earnings
by Zacks Equity Research
FEMSA's (FMX) Q2 results are expected to reflect gains from continued strength in OXXO Mexico and OXXO Gas, expansion into newer businesses, and digital initiatives amid cost woes.
Will Soft Shipment Trend Mar Boston Beer's (SAM) Q2 Earnings?
by Zacks Equity Research
Boston Beer's (SAM) Q2 results are expected to reflect the continued impacts of declining shipments and depletions, and challenges in the hard seltzer category.
Is a Beat in Store for Church & Dwight (CHD) in Q2 Earnings?
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter results are likely to reflect gains from pricing, innovation and demand amid elevated costs.
Coca-Cola (KO) Set to Beat Q2 Earnings: What Should You Know?
by Zacks Equity Research
Coca-Cola's (KO) Q2 results to reflect benefits from share gains in the at-home and away-from-home channels, and continued growth in the price/mix.
Factors to Decide Keurig Dr Pepper's (KDP) Fate in Q2 Earnings
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q2 results are expected to reflect headwinds related to input cost inflation, rising transportation costs and supply-chain disruptions.
4 Stocks Trading Near 52-Week High That Can Climb Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like TAP, ENS, PLAY and KBH that are seeing price strength have a high chance of carrying the momentum forward.
Will Molson Coors (TAP) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Molson Coors (TAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Factors Likely to Drive Archer Daniels' (ADM) Earnings in Q2
by Zacks Equity Research
Archer Daniels (ADM) Q2 results are likely to reflect the impacts of higher SG&A expenses, inflation and a continued decline in the Nutrition segment. However, its growth initiatives have been intact.
Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why You Should Hold Archer Daniels (ADM) Before Q2 Earnings
by Zacks Equity Research
Archer Daniels (ADM) looks poised for growth on progress on its three strategic pillars, as reflected by continued momentum in its top and bottom-line performance.
Best Income Stocks to Buy for July 18th
by Zacks Equity Research
ING, REPPY and TAP made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 18, 2023.
Brown-Forman's (BF.B) Brands & Strategies Provide Growth Impetus
by Zacks Equity Research
Brown-Forman (BF.B) continues to benefit from its strong brand portfolio, premiumization efforts and aggressive brand investments.